In a study of 1,194 KRAS-mutant NSCLC patients comparing KRAS G12C versus KRAS non-G12C mutations, co-mutation patterns of STK11 and KEAP1 were similar, and no significant differences were observed in median overall survival to single-agent ICI (50). Here, KRAS is linked to non-small cell lung carcinoma.